| Group | Chi-square tests (P value) | t-test (P value) | |||
---|---|---|---|---|---|---|
PSE + Hep + DEX group (N = 54) | PSE group (N = 62) | |||||
Post-Treatment ECOG | 0 | Count (%) | 19 (35.2%) | 29 (46.8%) | 0.260 | Â |
 | 1 | Count (%) | 30 (55.6%) | 25 (40.3%) |  |  |
 | 2 | Count (%) | 5 (9.2%) | 8 (12.9%) |  |  |
Post-treatment liver function | Child A | Count (%) | 43 (79.6%) | 49 (79.0%) | 0.937 | Â |
 | Child B | Count (%) | 11 (20.4%) | 13 (21.0%) |  |  |
Post-treatment bilirubin (μmol/L) | Mean ± SD |  | 15.2 ± 5.1 | 13.8 ± 5.5 |  | 0.163 |
Post-treatment Albumin (g/L) | Mean ± SD |  | 34.42 ± 3.06 | 33.58 ± 2.99 |  | 0.139 |
Post-treatment BUN (mmol/L) | Mean ± SD |  | 5.96 ± 1.48 | 6.15 ± 1.49 |  | 0.512 |
Post-Treatment Cr (μmol/L) | Mean ± SD |  | 72.2 ± 19.5 | 76.1 ± 20.9 |  | 0.309 |
Tests of Normality | ||
---|---|---|
 | Group | Kolmogorov–Smirnova |
 |  | P value |
Post-treatment bilirubin (μmol/L) | PSE + Hep + DEX group | 0.218 |
 | PSE group | 0.201 |
Post-treatment Albumin (g/L) | PSE + Hep + DEX group | 0.132 |
 | PSE group | 0.097 |
Post-treatment BUN (mmol/L) | PSE + Hep + DEX group | 0.324 |
 | PSE group | 0.166 |
Post-Treatment Cr (μmol/L) | PSE + Hep + DEX group | 0.253 |
 | PSE group | 0.107 |